Pilot Clinical Trial of NT-3 in CMT1A Patients

Progress in Neurotherapeutics and Neuropsychopharmacology

Volumn 2, Issue 1, 2007, Pages 97-108

  Sahenk, Zarife ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

CMT disease; NT 3; regeneration; Schwann cell

Indexed keywords

EID: 84964637667     PISSN: 17482321     EISSN: 1748233X     Source Type: Journal    
DOI: 10.1017/S1748232106000073     Document Type: Article

References (15)

1. Boyd, J.G., & Gordon, T. (2003). Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Molecular Neurobiology, 27(3), 277–324.
2. Dyck, P.J., Sherman, W.R., Hallcher, L.M., et al. (1980). Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Annals of Neurology, 8(6), 590–596.
3. Dyck, P.J., Litchy, W.J., Lehman, K.A., Hokanson, J.L., Low, P.A., & O'Brien, P.C. (1995). Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology, 45(6), 1115–1121.
4. Frostick, S.P., Yin, Q., & Kemp, G.J. (1998). Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery, 18(7), 397–405.
5. Martina, I.S., van Koningsveld, R., Schmitz, P.I., van der Meche, F.G., & van Doorn, P.A. (1998). Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. Journal of Neurology Neurosurgery and Psychiatry, 65(5), 743–747.
6. Meier, C., Parmantier, E., Brennan, A., Mirsky, R., & Jessen, K.R. (1999). Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. Journal of Neuroscience, 19, 3847–3859.
7. Mirsky, R., Jessen, K.R., Brennan, A., et al. (2002). Schwann cells as regulators of nerve development. Journal of Physiology Paris, 96(1–2), 17–24.
8. Mohiuddin, L., Fernandez, K., Tomlinson, D.R., & Fernyhough, P. (1995). Nerve growth factor and neurotrophin-3 enhance neurite outgrowth and up-regulate the levels of messenger RNA for growth-associated protein GAP-43 and T alpha 1 alpha-tubulin in cultured adult rat sensory neurones. Neuroscience Letter, 185(1), 20–23.
9. Oya, T., Zhao, Y.L., Takagawa, K., et al. (2002). Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia, 38(4), 303–312.
10. Sahenk, Z., Chen, L., & Mendell, J.R. (1999). Effects of PMP22 duplication and deletions on the axonal cytoskeleton [see comments]. Annals of Neurology, 45, 16–24.
11. Sahenk, Z., Serrano-Munuera, C., Chen, L., Kakabadze, I., & Najagara, H.N. (2003). Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts. Journal of the Peripheral Nervous System, 8(2), 116–127.
12. Sahenk, Z., Nagaraja, H., McCracken, B.S., King, W.M., Freimer, M.L., Cederbaum, J.M., & Mendell, J.R. (2005). Neurotrophin-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology, 54, 681–689.
13. Sunderland, S. (1952). Factors influencing the course of regeneration and quality of recovery after nerve suture. Brain, 75, 19–54.
14. Sterne, G.D., Brown, R.A., Green, C.J., & Terenghi, G. (1997). Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. European Journal of Neuroscience, 9(7), 1388–1396.
15. Syroid, D.E., Zorick, T.S., Arbet-Engels, C., Kilpatrick, T.J., Eckhart, W., & Lemke, G. (1999). A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience, 19, 2059–2068.